Profiel
Lisa Roberts currently works as the Head of Business Operations at Upperton Ltd.
Actieve functies van Lisa Roberts
Bedrijven | Functie | Begin |
---|---|---|
Upperton Ltd.
Upperton Ltd. Miscellaneous Commercial ServicesCommercial Services Upperton Ltd. is a British pharmaceutical company that offers a range of services to support product development, including identification, development, monitoring, and quality control testing. Upperton is based in Nottingham, UK, and was founded in 1999 by Richard Johnson. The company has an experienced analytical team that works in conjunction with formulators to ensure the success of all projects. The company offers flexible and dynamic GMP manufacturing services for clinical supplies, from first in human through to phase III clinical supplies manufacturing. The company has extensive experience taking research projects from early proof of concept and feasibility through scale-up and onto clinical manufacture for a range of common dosage forms. The CEO is Nikki Whitfield. | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Upperton Ltd.
Upperton Ltd. Miscellaneous Commercial ServicesCommercial Services Upperton Ltd. is a British pharmaceutical company that offers a range of services to support product development, including identification, development, monitoring, and quality control testing. Upperton is based in Nottingham, UK, and was founded in 1999 by Richard Johnson. The company has an experienced analytical team that works in conjunction with formulators to ensure the success of all projects. The company offers flexible and dynamic GMP manufacturing services for clinical supplies, from first in human through to phase III clinical supplies manufacturing. The company has extensive experience taking research projects from early proof of concept and feasibility through scale-up and onto clinical manufacture for a range of common dosage forms. The CEO is Nikki Whitfield. | Commercial Services |